International Day of LGBTQIA+ People in STEM celebrates the work of LGBTQIA+ people in science, technology, engineering, and maths.
We spoke to Dr Iñigo Martincorena, group leader at the Wellcome Sanger Institute and academic co-founder of Quotient Therapeutics. Quotient is a new company leveraging Sanger Institute research to innovate the way drugs are discovered.
As a top UK innovator, the Sanger Institute’s work is foundational to many. We enable partners to apply our science and advance it to develop products, services and therapeutics - solving real-world problems
The Sanger Institute is committed to innovative science at scale, but we need partners and investors to transfer this science into the clinic. Mariya Chhatriwala, Business Development Manager, gives us her insights on how the Sanger Institute’s fifth spin-out company came to be.
Histologists, cardiologists, immunologists, cell biologists, software developers, bioinformaticians and specialist technicians have worked together to see individual cells in unprecedented detail. Using spatial genomics, they located each cell to its precise location in the heart.
Chenqu Suo looks back on her PhD, discussing her scientific highlights and her thoughts about what makes the Sanger Institute a special place to study.
The Sanger Institute’s new Respiratory Virus and Microbiome Initiative will lead the way in developing the genomic tools and methodology to study and track a range of viruses and understand how they interact with the respiratory microbiome and human hosts.